Mahoney Stephen F.

CIK 00017413893 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001741389

Recent Transactions

25 trades

Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03+18,357→ 40,757 total
Tax Payment
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03$30.19/sh−7,408→ 33,349 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2026-03-03−18,357→ 55,071 total
Tax Payment
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03$29.32/sh−7,627→ 33,130 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2026-03-02+111,900→ 111,900 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2026-03-02+559,600→ 559,600 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2025-03-03+73,428→ 73,428 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2025-03-03+440,565→ 440,565 total
Purchase
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2024-09-27$23.33/sh+21,400→ 21,400 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2023-10-30+1,259,400→ 1,259,400 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2022-11-30$0.94/sh+3,000→ 17,264 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2022-08-01+130,000→ 130,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2022-05-17+62,500→ 62,500 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2022-02-15+130,000→ 130,000 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2021-09-16$6.73/sh−5,736→ 14,264 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2021-09-14+20,000→ 20,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-11-02+435,000→ 435,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2019-09-17+82,000→ 82,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2019-03-04+83,000→ 83,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2018-09-20+50,000→ 50,000 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series A Preferred Shares
2018-05-29−107,050→ 0 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Shares
2018-05-29+6,392→ 79,589 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-05-29−6,392→ 0 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class B Common Shares
2018-05-29+107,050→ 656,027 total
Purchase
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-02-09$15.64/sh+6,392→ 6,392 total

Companies

Recent Filings

Address

C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 103A

WALTHAM, MA, 02453

View on SEC.gov